Pola-R-GemOx treatment significantly improves overall survival for relapsed/refractory DLBCL patients ineligible for stem cell transplant,...
Advanced practitioners enhance myeloma care by improving specialty access and helping patients manage bispecific antibody...
New treatment approved for lung cancer patients with ROS1-positive non–small cell lung cancer.
Kaduna's river blindness fight targets hard-to-reach groups, addressing challenges in eliminating onchocerciasis through community drug...
Improved Kaduna health center faces access challenges despite better healthcare, impacting pregnant women and labor...
The ACO REACH model generated $2.5B in Medicare savings in 2024. Discover the financial and...
Medicare GLP‑1 bridge program lets eligible Part D beneficiaries pay a $50 monthly copay for...
Exercise boosts heart health more than weight-loss drugs, reducing inflammation and improving artery function for...
Researchers developed a fast tick disease test detecting Rocky Mountain spotted fever in 40 minutes,...
Blurry or gray letters on eye charts may reveal hidden vision issues like poor contrast...